Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
HHS Secretary Testifies on FY 2027 HHS Budget Before House, Senate Subcommittees
Secretary of Health and Human Services Robert F. Kennedy Jr. testified before two congressional subcommittees on the FY 2027 HHS budget, which seeks $111.1 billion in funding. The morning hearing was with the House Energy and Commerce Committee’s Health Subcommittee, and the afternoon session was with the Senate Appropriations Labor, Health and Human Services, Education Subcommittee. Kennedy had already appeared last week before the House Ways and Means Committee and the House Appropriations Subcommittee on Labor, Health and Human Services, Education. While non‑binding, the request sets the initial funding framework for upcoming legislative negotiations.
Aging Mechanisms Are Now Engineerable, Says SynBioBeta
Aging isn't just inevitable decline. It's a set of biological systems that are starting to look engineerable. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK DNA damage accumulates. Protein...
A Natural Protein May Protect the GI Tract From Infection
MIT researchers have identified the natural lectin protein intelectin‑2 as a dual‑action defender of the gastrointestinal tract. The protein binds galactose on bacterial membranes, trapping and destabilizing pathogens while also reinforcing the mucus barrier by attaching to mucins. Laboratory tests...
STAT+: Key GOP Senators Push Back on Trump’s Plan to Cut NIH, Reorganize HHS
During a Senate appropriations health subcommittee hearing, bipartisan senators questioned Health Secretary Robert F. Kennedy Jr. about the White House’s 2027 budget proposal that would slash the Department of Health and Human Services (HHS) by 12%. The plan calls for...
The Future of Mental Health and Substance Use Treatment: Technology, Policy, and Collaboration
On April 20, HHS convened a roundtable to explore how health‑IT can close gaps in mental health and substance‑use care. Officials highlighted the SUPPORT Act reauthorization and the Great American Recovery Initiative, which together channel billions into overdose prevention and treatment....
UnitedHealth to Expand Rural Payment Acceleration Pilot Program
UnitedHealth Group announced the expansion of its Rural Payment Acceleration Pilot, targeting faster Medicare Advantage reimbursements for rural hospitals. The initiative will extend accelerated payments to additional independent facilities in Alabama, Arkansas, Kentucky, Virginia and West Virginia immediately, and aims to...
AHA Chair Speaks at Politico Health Care Summit
Marc Boom, M.D., president and CEO of Houston Methodist and 2026 AHA board chair, addressed Politico’s Health Care Summit on April 21, 2026. He warned that the recent budget reconciliation bill is driving patients off insurance and into emergency rooms, inflating hospital...
Dietary Supplement Listing Bill Introduced in the House
Representative Maxine Dexter (OR‑03) introduced a House bill that would require dietary supplement manufacturers to submit detailed product information to the FDA, including names, full ingredient lists, labels, allergen statements, and health claims. The legislation calls for a searchable database...
Smart Toilets Turn Waste Into Real‑Time Health Data, Launching at $200‑$400
Kohler Health, Withings and Throne Science have rolled out AI‑driven smart toilet devices that analyze urine and stool for hydration, metabolism and disease markers. Priced between $200 and $400 with subscription fees, the gadgets aim to bring clinical‑grade monitoring into...
Medicare Indefinitely Delays Pilot Plan to Cover Weight Loss Drugs
Medicare’s Center for Medicare & Medicaid Services announced an indefinite postponement of its pilot program to cover prescription weight‑loss medications. The pilot, originally slated to test coverage for drugs such as Wegovy and Zepbound, was halted after participating insurers raised...
Interventional Radiologist Launches AI-Powered, IR-Specific Decision Support Platform
Interventional radiologist Dr. Syed Aziz Rahman unveiled VIRad.AI, an AI‑powered clinical decision‑support platform tailored for interventional radiology, at the Society of Interventional Radiology’s annual meeting. The tool combines an IR‑specific question bank, procedure reference library, device catalog, and an integrated...
STAT+: Insurers Refuse to Join Medicare Pilot Offering Weight Loss Drugs to Seniors at Steep Discount
The Trump administration negotiated a $245‑per‑month price with Eli Lilly and Novo Nordisk for obesity drugs, intending to offer seniors a $50 monthly copay through a Medicare pilot called BALANCE. Insurers refused to join, arguing the program would strain their finances. Consequently,...
Rep. Richard Neal and Steve Walsh Discuss Role of Hospitals, Future of the Enhanced Premium Tax Credits
Republican? Actually Neal is a Democrat. He discussed hospitals' community role and the expiration of the enhanced premium tax credits (EPTCs) with Massachusetts Health & Hospital Association CEO Steve Walsh. Neal criticized the December 2025 EPTC cuts as ill‑timed and signaled...
Sen. Josh Hawley Shares Priorities for Rural Hospitals, Affordability
Senator Josh Hawley outlined his rural hospital agenda, warning that recent provider tax changes in the budget reconciliation bill could harm rural providers. He called for doubling the Rural Health Transformation Fund to $100 billion and highlighted his sponsorship of the...
VSRF LIVE TONIGHT: Episode 224: Dr. Paul Marik and Dr. Pierre Kory
VSRF Live aired a special episode featuring Dr. Paul Marik and Dr. Pierre Kory, the co‑founders of the former FLCCC, now the Independent Medical Alliance. Both physicians discuss how they were marginalized for promoting off‑label COVID‑19 protocols and outline their current focus—Marik...
Trump's Order Is a Milestone for Proponents of Using Psychedelics as Medicine
President Trump signed an executive order that mandates federal agencies to speed up research and regulatory approval of psychedelic compounds for mental‑health treatment. The order calls for the DEA to reassess scheduling of substances such as psilocybin and MDMA and...
Lilly's Retatrutide Achieves 28.7% Weight Loss, Higher Dropouts
Lilly’s triple G agonist boasts 28.7% weight loss in Phase III trial Lilly is investigating retatrutide in seven other Phase III trials, which are due to read out in 2026. 👨🏻⚕️“Discontinuation rates due to adverse events were 12.2% and 18.2% with retatrutide...
Medi-Cal Immigrant Enrollment Falls by 100,000 as Policy Uncertainty Spurs Disenrollment
California’s Medicaid program, Medi-Cal, lost almost 100,000 undocumented immigrants between June and December, accounting for a quarter of all disenrollments. Researchers link the drop to heightened policy anxiety and renewed eligibility checks, while officials point to administrative factors.
Zero Relapses Reported in Pre‑Surgery Immunotherapy Trial for Bowel Cancer
University College London and UCL Hospitals reported that none of the 32 stage II/III bowel‑cancer patients in the NEOPRISM‑CRC trial relapsed after a median 33‑month follow‑up. The pre‑operative pembrolizumab regimen shrank tumours in 59% of participants and could cut the need...
Discovery of a Small Molecule HPK1 Inhibitor for Immuno-Oncology
A biotech firm has disclosed a novel small‑molecule inhibitor of hematopoietic progenitor kinase 1 (HPK1) that demonstrates potent immuno‑oncology activity in preclinical models. The compound achieves sub‑micromolar potency, oral bioavailability, and drives up to 70% tumor regression when combined with...
Debiopharm Secures FDA Fast Track for Lunresertib/Zedoresertib in Platinum‑Resistant Ovarian Cancer
Debiopharm announced that the FDA granted Fast Track designation to its lunresertib‑zedoresertib regimen for adult patients with CCNE1‑amplified or FBXW7/PPP2R1A‑mutated platinum‑resistant ovarian cancer. The move follows Phase I data presented at AACR 2026, positioning the combo as a potential first‑in‑class...
Hidden Surcharge
A recent HumbleDollar post highlights a little‑known Medicare surcharge that can turn a single extra dollar of income into an effective tax rate exceeding 1,000 percent. The surcharge, known as the Income‑Related Monthly Adjustment Amount (IRMAA), kicks in when a...
A Look Into an Upcoming AI-Powered Surgical Performance Center
A new AI‑powered Surgical Performance Center, built around OMNIMED’s SmartOR platform, is set to transform operating‑room training. The system fuses 3D video, audio and environmental sensors to generate objective performance baselines for surgeons and support staff. An integrated AI agent...
Radiopharmaceutical Manufacturer Secures $30M to Bolster Domestic Isotope Production
Ionetix Corporation, a Michigan‑based cyclotron and radiopharmaceutical firm, announced a $30 million private‑placement raise at $3 per share. The capital will fund expansion of domestic radioisotope production for PET imaging and alpha‑emitter therapies and boost R&D on its superconducting cyclotron platform....
House FY27 VA Funding Bill Allocates $3.4B for EHR Rollout
The House Appropriations Committee approved a FY27 funding package that earmarks $3.4 billion for the Veterans Affairs (VA) electronic health record (EHR) modernization. The allocation matches FY26 levels but ties 25% of the money to performance metrics and quarterly reporting, with...
AACR 2026: Lung Cancer Immunotherapy Response Predicted by Pathomics AI Model
Researchers at UT MD Anderson unveiled Path-IO, a deep‑learning pathomics model that predicts outcomes and immunotherapy response in metastatic non‑small cell lung cancer (NSCLC). The AI was trained on 797 patients and externally validated on 280 cases, consistently outperforming the...
Sirolimus- and Paclitaxel-Coated Balloons Deliver Comparable 1-Year PCI Outcomes
A nationwide Swedish registry analysis of more than 8,000 percutaneous coronary intervention (PCI) patients found that sirolimus‑coated balloons (SCBs) and paclitaxel‑coated balloons (PCBs) deliver comparable one‑year clinical outcomes. While PCBs showed a modest advantage in reducing in‑stent restenosis, rates of...
AcuityMD Closes $80M Series C Led by StepStone Group
AcuityMD, the Boston‑based AI platform for medical‑device sales teams, closed an $80 million Series C round led by StepStone Group, bringing its valuation to $955 million. The funding, also backed by Benchmark, Redpoint Ventures, ICONIQ and Atreides, will fuel the rollout of "agentic...
Surgery or Bracing for Burst Fractures: No Difference?
A multinational AO Spine Knowledge Forum study compared surgical fixation to non‑operative bracing in 93 neurologically intact adults with thoracolumbar burst fractures. Using the trauma‑specific AO Spine PROST outcome measure, both cohorts improved from baseline scores of 34‑40 to around...
Scaling Bio 008: Serif Biomedicines' Jake Rubens on Turning Modified DNA Into a New Class of Medicine
In this episode, Jake Rubens of Serif Biomedicines explains how the company is turning DNA into a new class of medicines by using chemically modified DNA and a protein co‑factor to overcome DNA’s historic immunogenicity and delivery challenges. He contrasts...
Sen. Amy Klobuchar Discusses Need to Address Prior Authorization, Workforce, Telehealth in Rural Areas
Senator Amy Klobuchar urged Congress to address recent health‑care funding cuts, burdensome prior‑authorization processes, workforce shortages, and inadequate rural telehealth infrastructure. She is sponsoring the Improving Seniors’ Timely Access to Care Act (H.R. 3514/S. 1816) to require standardized electronic prior authorizations and...
CMS Announces Hospital Food Pledge
The Centers for Medicare & Medicaid Services (CMS) unveiled a voluntary pledge for hospitals to align patient food services with the 2025‑2030 Dietary Guidelines for Americans. The pledge calls for meals that meet individual nutritional needs, support healing and recovery,...
VA Accelerates Electronic Health Record Deployment to Improve Veteran Services in Michigan
The Department of Veterans Affairs has gone live with its new Federal Electronic Health Record system at four Michigan hospitals on April 11, marking the first wave of 13 deployments planned for 2026. The accelerated rollout replaces fragmented legacy platforms and...
Exclusive: Michigan US Senate Candidate Dr. Abdul El-Sayed on Healthcare, Trump and More
In this episode, Michigan Democratic Senate candidate Dr. Abdul El‑Sayed, a physician‑epidemiologist, discusses his push for universal, single‑payer health care, emphasizing that the system’s cost is a major burden for Americans and that corporate money has corrupted Democratic messaging. He...
HIMSS Measures Healthcare AI Progress and Shares Successful Strategies
HIMSS has launched its 2026 AI Adoption Index, a comprehensive benchmark that evaluates how hospitals and health systems are integrating artificial intelligence across clinical and operational domains. The index surveyed more than 500 institutions, identifying the AI techniques that deliver...
Beyond CAR T: Programmable Immune Cells Shaping Future Therapies
CAR T cells cured patients who had no other options. That was just the opening move. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK The next generation of T...
Part 2: The Spaces Between
Bright Frontier, a new platform founded by Janis Naeve and Tim Fitzpatrick, maps systemic gaps in kidney and cardiometabolic (CKM) care and proposes four critical "bridges"—signal to decision, decision to action, action to accountability, and accountability to signal. The analysis...
The BioPharm Brief: AI, Immunology, and Regulatory Momentum
AstraZeneca announced consistent Phase III data showing its IL‑33 biologic cuts COPD exacerbations, reinforcing the cytokine as a therapeutic target. Boehringer Ingelheim disclosed a broadened AI program that will be embedded across early discovery and development stages to speed target identification. The...
Antibiotics Leave Lasting Mark on Baby Immune Systems
Researchers at University of Rochester Medicine discovered that antibiotics given to newborns disrupt the gut microbiome, which in turn reprograms lung immune cells from an aggressive, infection‑fighting mode to a repair‑focused stance. This shift persists into young adulthood in mouse...
Skip the Car? Active Commuting and Coronary Atherosclerosis
A new analysis of the Swedish CArdioPulmonary bioImage Study (SCAPIS) examined 23,000 adults aged 50‑64 and found that people who walk or cycle to work have less coronary artery stenosis and lower calcium scores than car commuters. The association persisted...
Survey: U.S. Adults Agree Health Care Is a Right and Eliminating Health Inequities Is a Priority
A new Institute for Policy Solutions survey of 1,578 U.S. adults finds a strong majority view health care as a right and support eliminating health inequities. Seventy‑one percent say access is a right, while 70 percent want the nation to...
Hegseth Says U.S. Military No Longer Requires Flu Vaccination, Drawing Criticism From Health Experts
Secretary of Defense Pete Hegseth announced that the U.S. military will no longer require annual flu vaccinations for service members, ending a long‑standing mandatory policy. The move contradicts CDC guidance, which credits the flu shot with saving roughly 12,000 lives...
1 Parkinson’s Drug Can Hinder the Gold-Standard Treatment
Researchers at Yale School of Medicine discovered that catechol‑O‑methyltransferase inhibitors (COMT‑Is), commonly added to levodopa therapy for Parkinson's disease, can unintentionally reshape the gut microbiome. The altered microbiome favors growth of Enterococcus faecalis, a bacterium that metabolizes levodopa before it...
RFK Jr. Says China Is 'Eating Our Lunch' In Biotech Advances
HHS Secretary Robert F. Kennedy Jr. warned Congress that China is outpacing the United States in biotech, citing faster new‑drug approvals and a surge in clinical‑trial starts. He highlighted that China approved more than 70 novel therapies in 2025, compared with roughly 45...
Dangers Coming From Inside the House
John D. Spengler, a pioneer in indoor air quality research, reflects on five decades of work that reshaped public health policies—from smoking bans on airplanes to reducing asthma triggers in public housing. His early findings from the 1970s Six Cities...
From Dashboards to Decision‑Making: Voice‑Chat Analytics
The next enterprise advantage will not come from more dashboards. It will come from systems that let executives ask: What changed? Why does it matter? What are my options? What could make this wrong? I’ve wanted to build that for...
Monoclonal Antibodies Boost Fight Against Infectious Diseases
This is a great conversation w @Invivyd chairman and @politico today on why monoclonal antibodies will enhance our war against infectious diseases.
Cancer Care’s Hidden Burden: 54 Days of Time Toxicity
At Cedars-Sinai, Dr. Khrystyna Levytska reveals underrecognized issue in cancer care: time toxicity Patients spend median of 54 d/yr interacting w/ healthcare As people live longer, we have to improve how they spend that time Solutions: bundle care, expand home-based services https://t.co/4c23jVbBYO
RFK Jr
RFK Jr. says China is 'eating our lunch' in biotech advances - but said Makary’s actions so far have been sufficient - also pledged support for Trump’s CDC nominee https://t.co/LMh0dShbYz
AI Speeds Disease Insight and Treatment Discovery
AI accelerates disease understanding and treatment discovery. https://t.co/pE6ppH5VR8 #sustainability #infrastructure #IoT #AI #5G #cloud #edge #futureofwork @virginia_tech https://t.co/k0Kpc0ATAF